Rethinking the INN system for therapeutic antibodies.

about

MABp1 for the treatment of colorectal cancer.Strategies and challenges for the next generation of antibody-drug conjugates.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.

P2860

Q38686881-B19A02A7-3C59-46CC-B7CD-CCE568E98A4D Q39182945-16DD99C9-9E6A-459B-A9C1-932FA5E1DE41 Q55283747-4FA1C154-0608-4011-B80F-401CE951FDED

P2860

Rethinking the INN system for therapeutic antibodies.

Item

http://www.wikidata.org/entity/Q41821601

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Rethinking the INN system for therapeutic antibodies.

@en

type

Item

label

Rethinking the INN system for therapeutic antibodies.

@en

prefLabel

Rethinking the INN system for therapeutic antibodies.

@en

P1476

Rethinking the INN system for therapeutic antibodies.

@en

P2093

Christophe Dumet

http://www.w3.org/2001/XMLSchema#string

Hervé Watier

http://www.w3.org/2001/XMLSchema#string

Jérémy Pottier

http://www.w3.org/2001/XMLSchema#string

Romane Chastang

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunoglobulin allotypes: possible implications for immunogenicity

Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes

Antibody humanization: a case of the 'Emperor's new clothes'?

Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies.

The covalent structure of an entire gammaG immunoglobulin molecule.

IgG subclasses and allotypes: from structure to effector functions.

Localization of antibody-combining sites within the variable portions of heavy and light chains.

Conformation of the human immunoglobulin G2 hinge imparts superagonistic properties to immunostimulatory anticancer antibodies.

The INNs and outs of antibody nonproprietary names.

Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14.18K322A

P304

5-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19420862.2016.1255520

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27808597

http://www.w3.org/2001/XMLSchema#string

P932

5240647

http://www.w3.org/2001/XMLSchema#string

Rethinking the INN system for therapeutic antibodies.

about

P2860

P2860

Rethinking the INN system for therapeutic antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932